A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults
Clinical trial NCT02416453 · COMPLETED
Trial details
- NCT number
- NCT02416453
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2018-01-19
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.